Arno Brandt

610 total citations
21 papers, 407 citations indexed

About

Arno Brandt is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Surgery. According to data from OpenAlex, Arno Brandt has authored 21 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Economics and Econometrics and 4 papers in Surgery. Recurrent topics in Arno Brandt's work include Diabetes Treatment and Management (9 papers), Diabetes Management and Research (6 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Arno Brandt is often cited by papers focused on Diabetes Treatment and Management (9 papers), Diabetes Management and Research (6 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Arno Brandt collaborates with scholars based in Switzerland, Germany and Sweden. Arno Brandt's co-authors include Michael Drummond, Bryan R. Luce, Joan Rovira, Stefan Krätke, Andrew Palmer, Helmut Wenzel, Giatgen A. Spinas, Kurt Neeser, Parham Sendi and Matthias Kiese and has published in prestigious journals such as Diabetologia, Diabetic Medicine and Diabetes Research and Clinical Practice.

In The Last Decade

Arno Brandt

12 papers receiving 378 citations

Peers

Arno Brandt

EDM

GHP

SURGE

EPIDE

Karen Van Nuys United States

Maria Raikou United Kingdom

John Abramson United States

Jari Kankaanpää Finland

Gisbert Selke Germany

Brett Wendling United States

Willemien Schurer United Kingdom

Manoela Manova Bulgaria

Tomasz Hermanowski Poland

Onur Başer Türkiye

Karen Van Nuys United States

Arno Brandt

128 ×0.7

139 ×1.1

EDM

56 ×0.6

GHP

47 ×0.9

SURGE

60 ×1.5

EPIDE

Citations per year, relative to Arno Brandt Arno Brandt (= 1×) peers Karen Van Nuys

Countries citing papers authored by Arno Brandt

Since Specialization

Citations

This map shows the geographic impact of Arno Brandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arno Brandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arno Brandt more than expected).

Fields of papers citing papers by Arno Brandt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arno Brandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arno Brandt. The network helps show where Arno Brandt may publish in the future.

Co-authorship network of co-authors of Arno Brandt

This figure shows the co-authorship network connecting the top 25 collaborators of Arno Brandt. A scholar is included among the top collaborators of Arno Brandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arno Brandt. Arno Brandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kero, Tanja, Christian L. Polte, Kai M. Eggers, et al.. (2025). Impact of hemoglobin concentration on quantitative cardiac perfusion measurements. Journal of Nuclear Cardiology. 55. 102537–102537.

Brandt, Arno, et al.. (2023). Zur Rolle industrieller Beziehungen in der sozial-ökologischen Transformation. Vierteljahrshefte zur Wirtschaftsforschung. 92(4). 63–84.

Brandt, Arno, et al.. (2023). Deindustrialisierung, Transformation und eine moderne Industriepolitik. Wirtschaftsdienst. 102(12). 918–921. 1 indexed citations

Müller, Klaus, et al.. (2017). Situations- und Potenzialanalyse Handwerk in Hamburg - Kurzfassung. RePEc: Research Papers in Economics. 1 indexed citations

Wiese, Anne, et al.. (2014). Revealing Relevant Proximities. Knowledge Networks in the Maritime Economy in a Spatial, Functional and Relational Perspective. Raumforschung und Raumordnung / Spatial Research and Planning. 72(4). 7 indexed citations

Roze, S, et al.. (2014). Health‐economic analysis of real‐time continuous glucose monitoring in people with Type 1 diabetes. Diabetic Medicine. 32(5). 618–626. 33 indexed citations

Brandt, Arno. (2010). Joseph Stiglitz: Im freien Fall – Vom Versagen der Märkte zur Neuorientierung der Weltwirtschaft. 3(2). 2 indexed citations

Brandt, Arno, et al.. (2010). Entwicklungspotenziale und Netzwerkbeziehungen maritimer Cluster in Deutschland. Zeitschrift für Wirtschaftsgeographie. 54(1). 238–253. 4 indexed citations

Krätke, Stefan & Arno Brandt. (2008). Knowledge Networks as a Regional Development Resource: A Network Analysis of the Interlinks between Scientific Institutions and Regional Firms in the Metropolitan region of Hanover, Germany. European Planning Studies. 17(1). 43–63. 26 indexed citations

10.

Brandt, Arno, et al.. (2001). Economic and clinical impact of alternative disease management strategies for secondary prevention in diabetes type 2 in the Swiss setting. Swiss Medical Weekly. 131(2122). 303–310. 23 indexed citations

11.

Brandt, Arno, et al.. (2001). PDG11: HEALTH AND ECONOMIC OUTCOMES OF A NEW ORAL DIABETES DRUG, PIOGLITAZONE (ACTOS*NF, TAKEDA), IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS IN NORWAY. Value in Health. 4(6). 506–506.

12.

Henriksson, Freddie, et al.. (2001). PDG6: COST-EFFECTIVENESS OF PIOGLITAZONE (ACTOS®, TAKEDA) IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS IN SWEDEN. Value in Health. 4(6). 504–504.

13.

Maniadakis, N, et al.. (2001). PDG14: AN ASSESSMENT OF THE COSTEFFECTIVENESS OF PIOGLITAZONE (ACTOS*NF, TAKEDA) IN TYPE 2 DIABETES MELLITUS IN DENMARK. Value in Health. 4(6). 507–508.

14.

Maniadakis, N, et al.. (2001). PDG1: THE OUTCOMES OF LONG-TERM TREATMENT OF A NEW ORAL DIABETES DRUG PIOGLITAZONE (ACTOS **) IN THE MANAGEMENT OF TYPE 2 DIABETES IN FINLAND. Value in Health. 4(6). 502–502.

15.

Palmer, Andrew, Parham Sendi, Kurt Neeser, et al.. (2000). The cost-effectiveness of different management strategies for Type I diabetes: a Swiss perspective. Diabetologia. 43(1). 13–26. 73 indexed citations

16.

Palmer, Andrew, et al.. (2000). Outline of a diabetes disease management model: principles and applications. Diabetes Research and Clinical Practice. 50. S47–S56. 26 indexed citations

17.

Palmer, Andrew, et al.. (2000). Cost-effectiveness of adding either pioglitazone or acarbose to metformin in the United Kingdom. Diabetes Research and Clinical Practice. 50. 193–194.

18.

Palmer, Andrew, et al.. (2000). Cost-effectiveness of pioglitazone versus acarbose, metformin, and sulphonylureas in the United Kingdom. Diabetes Research and Clinical Practice. 50. 193–193.

19.

Bergemann, R, Arno Brandt, & Walter Siegrist. (1993). Cost-Effectiveness Study of a Lipid-Lowering Therapy in Hyperlipoproteinaemia Type IIb and Type IV (Frederickson). PharmacoEconomics. 3(2). 131–139. 2 indexed citations

20.

Drummond, Michael, Arno Brandt, Bryan R. Luce, & Joan Rovira. (1993). Standardizing Methodologies for Economic Evaluation in Health Care: Practice, Problems, and Potential. International Journal of Technology Assessment in Health Care. 9(1). 26–36. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact